| Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels … J Stasakova, B Ferko, C Kittel, S Sereinig, J Romanova, H Katinger, ... Journal of general virology 86 (1), 185-195, 2005 | 243 | 2005 |
| Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes B Ferko, J Stasakova, J Romanova, C Kittel, S Sereinig, H Katinger, ... Journal of virology 78 (23), 13037-13045, 2004 | 181 | 2004 |
| Rescue of influenza virus expressing GFP from the NS1 reading frame C Kittel, S Sereinig, B Ferko, J Stasakova, J Romanova, A Wolkerstorfer, ... Virology 324 (1), 67-73, 2004 | 118 | 2004 |
| Identification and characterization of a novel mammalian caspase with proapoptotic activity L Eckhart, C Ballaun, A Uthman, C Kittel, M Stichenwirth, M Buchberger, ... Journal of Biological Chemistry 280 (42), 35077-35080, 2005 | 95 | 2005 |
| Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment C Kittel, B Ferko, M Kurz, R Voglauer, S Sereinig, J Romanova, G Stiegler, ... Journal of virology 79 (16), 10672-10677, 2005 | 89 | 2005 |
| Influenza Virus NS Vectors Expressing the Mycobacterium tuberculosis ESAT-6 Protein Induce CD4+ Th1 Immune Response and Protect Animals against … S Sereinig, M Stukova, N Zabolotnyh, B Ferko, C Kittel, J Romanova, ... Clinical and vaccine immunology 13 (8), 898-904, 2006 | 88 | 2006 |
| The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections KH Müller, DE Kainov, K El Bakkouri, X Saelens, JK De Brabander, ... British journal of pharmacology 164 (2), 344-357, 2011 | 68 | 2011 |
| Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein MA Stukova, S Sereinig, NV Zabolotnyh, B Ferko, C Kittel, J Romanova, ... Tuberculosis 86 (3-4), 236-246, 2006 | 65 | 2006 |
| Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate N Wressnigg, D Voss, T Wolff, J Romanova, T Ruthsatz, I Mayerhofer, ... Vaccine 27 (21), 2851-2857, 2009 | 44 | 2009 |
| Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts B Ferko, C Kittel, J Romanova, S Sereinig, H Katinger, A Egorov Journal of virology 80 (23), 11621-11627, 2006 | 43 | 2006 |
| Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice N Wressnigg, AP Shurygina, T Wolff, M Redlberger-Fritz, T Popow-Kraupp, ... Journal of General Virology 90 (2), 366-374, 2009 | 30 | 2009 |
| DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice RA Rasmussen, H Ong, C Kittel, CR Ruprecht, F Ferrantelli, SL Hu, ... Vaccine 24 (13), 2324-2332, 2006 | 26 | 2006 |
| Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency M Wolschek, E Samm, H Seper, S Sturlan, I Kuznetsova, C Schwager, ... Journal of virology 85 (5), 2469-2473, 2011 | 25 | 2011 |
| Generation of recombinant influenza virus using baculovirus delivery vector K Poomputsa, C Kittel, A Egorov, W Ernst, R Grabherr Journal of virological methods 110 (1), 111-114, 2003 | 24 | 2003 |
| Identification of a novel exon encoding the amino-terminus of the predominant caspase-5 variants L Eckhart, C Kittel, S Gawlas, F Gruber, M Mildner, B Jilma, E Tschachler Biochemical and biophysical research communications 348 (2), 682-688, 2006 | 16 | 2006 |
| Replication deficient influenza virus for the expression of heterologous sequences M Wolschek, A Egorov, M Bergmann, T Muster, C Kittel US Patent App. 12/666,246, 2010 | 7 | 2010 |
| Caspase-15 is autoprocessed at two sites that contain an aspartate residue in the P1′ position L Eckhart, C Kittel, C Ballaun, E Tschachler Biochemical and biophysical research communications 350 (4), 955-959, 2006 | 6 | 2006 |
| Optimization of baculovirus transduction on freestyleTM293 cells for the generation of influenza B/Lee/40 S Nakowitsch, C Kittel, W Ernst, A Egorov, R Grabherr Molecular Biotechnology 34, 157-164, 2006 | 6 | 2006 |
| Modified influenza virus C Kittel, N Wressnigg US Patent 8,592,196, 2013 | 4 | 2013 |
| A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice C Kittel, N Wressnigg, AP Shurygina, M Wolschek, M Stukova, ... Archives of virology 160 (10), 2525-2534, 2015 | 3 | 2015 |
